Evidence map›Paper›PMID 41996356›Full record

ArticlePloS one2026

DJ-1 alleviates high glucose-induced podocyte injury via activating ERK1/2 signaling.

Xiaochen Tian, Jing Li, Tao Han, Leisheng Zhang, Ping Lu, Yusheng Liu

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaochen TianShandong University, Jinan, China.
Jing LiInternal Medicine of Jinan Municipal Government Hospital, Jinan, China.
Tao HanCommunity Management Department of The Fourth People's Hospital of Jinan, Jinan, China.
Leisheng ZhangThe Fourth People's Hospital of Jinan, Shandong Second Medical University, Jinan, China.ORCID https://orcid.org/0000-0001-6540-0943
Ping LuThe Fourth People's Hospital of Jinan, Shandong Second Medical University, Jinan, China.ORCID https://orcid.org/0009-0008-0189-0187
Yusheng LiuShandong University, Jinan, China.ORCID https://orcid.org/0000-0002-1056-1317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is a major diabetic complication, and while DJ-1 has been shown to mitigate renal ischemia/reperfusion injury, its role in high glucose-induced podocyte damage remains unclear. This study aimed to investigate the function and mechanism of DJ-1 in high glucose-induced injury of human podocyte cells (HPCs). Using RNA-seq analysis, we identified that high glucose broadly affected multiple signaling pathways related to cell growth, death, and signal transduction. Notably, DJ-1 expression was downregulated under high glucose conditions. Overexpression of DJ-1 significantly attenuated high glucose-induced HPC apoptosis. Mechanistically, DJ-1 promoted the phosphorylation of ERK1/2 and facilitated the nuclear translocation of p-ERK1/2. This activated the ERK1/2 pathway and upregulated the expression of NF-κB p65 and AP-1, thereby suppressing HPC apoptosis under high glucose conditions. In summary, our findings reveal that DJ-1 protects against high glucose-induced HPC injury by activating the ERK1/2 pathway and enhancing NF-κB p65 and AP-1 expression, providing new insights into the molecular mechanisms of DJ-1 in diabetic nephropathy.

Indexed as

GlucoseMAP Kinase Signaling SystemPodocytesProtein Deglycase DJ-1ApoptosisCell LineDiabetic NephropathiesHumansPhosphorylationTranscription Factor AP-1Transcription Factor RelAGlucosePARK7 protein, humanProtein Deglycase DJ-1Transcription Factor AP-1Transcription Factor RelA

Identifiers

PMID41996356
PMCPMC13089688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.